Latest Reports

Market Scope’s "2025 Corneal Disease Model" delivers detailed, country-level insight into corneal disease prevalence worldwide, with age-specific estimates and five-year forecasts across nine corneal indications for every country with a population over one million.

Built on the latest clinical literature and global demographic projections, this proprietary model provides a consistent, forward-looking view of corneal disease prevalence. The model can be customized by geography and disease category to support strategic planning, including market sizing, evaluation of target populations for clinical- and commercial-stage products, and analysis of how corneal disease demographics are expected to evolve over time.

Market Scope’s “2025 Ophthalmic Diagnostic Equipment Survey Report” provides a data-driven snapshot of how United States ophthalmologists and optometrists are evaluating, purchasing, and using diagnostic technologies in today’s evolving clinical environment.  

Based on a nationwide online survey of 480 verified providers, the report delivers direct insight into capital investment priorities, technology adoption, and the growing influence of digital tools, AI, and data integration across ophthalmic practices.  

This survey report examines how and why purchasing decisions are made, what features and services matter most, how diagnostic budgets are changing, and where practices see value in next-generation technologies. Coverage spans core diagnostic categories as well as fast-growing areas such as artificial intelligence, interoperability, digital applications, and telehealth—offering both a current-state assessment and a forward-looking view of the diagnostic landscape. 

Survey questions were developed by Market Scope in collaboration with sponsoring companies, ensuring the data addresses the most commercially and strategically relevant issues facing diagnostic equipment manufacturers.  

The “2025 Cataract Pharmaceuticals Market Report” provides a comprehensive, data-driven market analysis of the drugs used before, during, and after cataract surgery in the United States and Western Europe. The report examines current utilization patterns and provides five-year forecasts for revenue by product category. 

Coverage includes antibiotics, anti-inflammatory agents, mydriatics/cycloplegics, pain management drugs, and intracameral formulations, along with a detailed look at fixed combinations, branded products, generics, and compounded alternatives. The report also explores evolving surgical practices, the growing role of intracameral injections, reimbursement dynamics, and the competitive pipeline shaping the future of cataract pharmaceuticals.  

The “2025 Dry Eye Pharmaceuticals Market Report” provides a comprehensive analysis of the global market for dry eye therapeutics, examining the disease’s prevalence, diagnosis, and treatment landscape. The report provides in-depth coverage of artificial tears, anti-inflammatory drops, miticides, tear evaporation inhibitors, mucin secretagogues, and other prescription and over-the-counter products—with detailed forecasts of unit demand, sales revenue, and market performance by region through 2030. 

The report offers a data-driven assessment of the current dry eye marketplace and its growth potential, highlighting new product development, emerging drug-delivery methods, and the expanding pharmaceutical pipeline. Global and regional forecasts are presented for seven major regions, with coverage of competitive dynamics, regulatory differences, and therapeutic trends. Profiles are provided for 23 leading companies and their strategic positioning within the dry eye market. 

The new first-edition “2025 Dry Eye Device Market Report” delivers a comprehensive analysis of the global market for the devices and procedures used in the diagnosis and treatment of dry eye disease. The report examines the drivers behind device adoption, evaluates current and emerging technologies, and forecasts procedure volumes, unit demand, and market performance through 2030. 

Competitive dynamics are analyzed across key product categories, including thermal expression devices, light-based systems, punctum plugs, eyelid debridement, scleral lens and amniotic tissue procedures, and other technologies, with detailed profiles of leading manufacturers and their strategic positioning. 

Market Scope’s “2025 Myopia Management Survey Report” delivers a comprehensive, provider-level view of how pediatric myopia is being managed in the United States today—examining patient volumes, treatment mix, economics, unmet needs, and how clinical behavior is likely to shift as new therapies reach the market. 

Conducted in August and September 2025, the survey captures insights from 150 US-based optometrists and ophthalmologists, including comprehensive and pediatric specialists actively treating myopia. Respondents were drawn from Market Scope’s self-registered provider community and reflect real-world clinical decision-makers with direct experience in myopia control. 

The report provides a structured summary analysis of de-identified survey data, calculated at the respondent level and presented without market extrapolation to clearly show how providers are thinking, prescribing, pricing, and planning. 

Our coverage of the US retina market includes a quarterly surveying process that targets and collects data from retina specialists. The resulting data are analyzed and presented in our Ophthalmic Market Trends: Quarterly US Retina Editions. These editions are designed to improve your decision-making process with an assessment of current market conditions and the identification of significant market trends -- including retinal patient care, product use and market share, product adoption plans, and doctors’ evaluations of pharmaceuticals and surgical equipment.

Each update includes full-year forecasts, comparisons with prior years, and trend analysis.

Our coverage of the refractive surgery market includes a quarterly surveying process that targets and collects data from US refractive surgeons. The resulting data are analyzed and presented in our Ophthalmic Market Trends: Quarterly US Refractive Editions. These editions are designed to improve your decision-making process with the most accurate assessment of current market conditions and the identification of significant market trends. 

The Ophthalmic Market Trends: Quarterly US Glaucoma Editions deliver essential, data-driven insights into the US glaucoma surgery market. These reports, based on quarterly surveys of glaucoma surgeons, provide a comprehensive analysis of key metrics such as patient diagnoses, treatment regimens, medication usage, surgical procedure volumes, and emerging trends in MIGS, canal-based procedures, and investigational treatments. With in-depth trend analysis, full-year forecasts, and year-over-year comparisons, these editions equip you with the latest information on product adoption, market share, and treatment strategies, ensuring you make informed, strategic decisions in the glaucoma treatment landscape.

Our coverage of the cataract surgery market includes a quarterly surveying process that targets and collects data from US cataract surgeons. The resulting data are analyzed and presented in our Ophthalmic Market Trends: Quarterly US Cataract Editions. These editions are designed to improve your decision-making process with the most accurate assessment of current market conditions and the identification of significant market trends.